The number of people with susceptibility test result for rifampicin in El Salvador
El Salvador: The number of people with susceptibility test result for rifampicin was 26.6 in 2021. ▼ Falling
Latest (2021)
26.6
Change on year
down 32.7%
World rank
135th
of 146 countries
All-time high
43.62
in 2017
All-time low
26.39
in 2019
Years of data
5
2017–2021
The number of people with susceptibility test result for rifampicin in El Salvador, 2017–2021
Source: World Health Organization, Global Health Observatory.
Analysis
El Salvador recorded 26.6 for the number of people with susceptibility test result for rifampicin in 2021.
That represents a change of down 32.7% on the previous year and down 39.0% over five years.
That places El Salvador 135th out of 146 countries with data for 2021, putting it in the bottom quarter.
The number of people with susceptibility test result for rifampicin in El Salvador, year by year
| Year | Value | Change |
|---|---|---|
| 2017 | 43.62 | — |
| 2018 | 32.37 | -25.8% |
| 2019 | 26.39 | -18.5% |
| 2020 | 39.53 | +49.8% |
| 2021 | 26.6 | -32.7% |
El Salvador compared with similar countries
- El Salvador's 26.6 is below the median for upper middle income countries, which is 92.7, 29% of the median. (45 countries reporting)
- El Salvador's 26.6 is below the median for Latin America & Caribbean, which is 59.38, 45% of the median. (21 countries reporting)
Averages by decade
| Decade | Average | Lowest | Highest | Years |
|---|---|---|---|---|
| 2010s | 34.13 | 26.39 | 43.62 | 3 |
| 2020s | 33.06 | 26.6 | 39.53 | 2 |
Countries ranked near El Salvador
More health data for El Salvador
- Un projection of annual infant deaths, annual growth rate -1.89 % change on previous year (2100)
- Heat deaths vs projected death rates, annual growth rate 0.4574 % change on previous year (2090)
- Estimated changes in temperature-related death rates compared to projected death rates 1,537 deaths per 1,000 people (2090)
- Number of infants who die before age 1 104 deaths (2100)
- Neonatal tetanus - number of reported cases, gaps filled 0 (2025)
- Population ages 00-04, female, annual growth rate -0.9135 % change on previous year (2025)
- Population ages 00-04, female, per unit of GDP 0 units per US$ of GDP (2025)
- Population ages 00-04, female, per capita 0.0374 units per person (2025)
- Population ages 00-04, male, annual growth rate -0.8849 % change on previous year (2025)
- Population ages 00-04, male, per unit of GDP 0 units per US$ of GDP (2025)
Frequently asked questions
- What is the number of people with susceptibility test result for rifampicin in El Salvador?
- The number of people with susceptibility test result for rifampicin in El Salvador was 26.6 in 2021, according to World Health Organization, Global Health Observatory.
- What is the highest the number of people with susceptibility test result for rifampicin recorded in El Salvador?
- The highest recorded value was 43.62 in 2017.
- What is the lowest the number of people with susceptibility test result for rifampicin recorded in El Salvador?
- The lowest recorded value was 26.39 in 2019.
- How does El Salvador rank for the number of people with susceptibility test result for rifampicin?
- El Salvador ranks 135th out of 146 countries with data for 2021.
- Where does this El Salvador data come from?
- The figures come from World Health Organization, Global Health Observatory, published as part of The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients expressed as percentage.. Statizoid updates them automatically from the source API.
Download this data
CSV · JSON — 5 observations, free to reuse under CC BY-NC-SA 3.0 IGO (WHO).